COVID-19 vaccine candidate MVA-CoV2-S confers full protection against SARS-CoV-2 neuroinvasion in humanized mice, preventing brain viral replication and the associated neuronal and vascular damage, even after reinfection, according to a paper published in Nature Neuroscience
nature.comSubmitted by MistWeaver80 t3_10fzltv in science
Viewing a single comment thread. View all comments